Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jelle Klein
Observed name:
Klein, Jelle
Institution:
SGS (Belgium)
Observed institutions:
University of Antwerp,
SGS (Belgium),
Institute Born-Bunge
ORCID:
0009-0006-7797-5588
Observed ORCID:
0009-0006-7797-5588
OpenAlex ID:
A5065415579
Predicting discharge destination after stroke: A systematic review
2016
·
Margot Mees
, Jelle Klein
, et al.
·
Clinical Neurology and Neurosurgery
·
103
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study
2022
·
Odile Launay
, Cécile Artaud
, et al.
·
EBioMedicine
·
33
PDF
Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study
2024
·
Thomas G Evans
, Flora Castellino
, et al.
·
The Lancet Microbe
·
14
Proof of stability of an RSV Controlled Human Infection Model challenge agent
2024
·
Sandra Verstraelen
, Dirk Roymans
, et al.
·
Virology Journal
·
3
PDF
Why do healthy volunteers participate in clinical trials?
2026
·
Thijs van Iersel
, Jelle Klein
, et al.
·
British Journal of Clinical Pharmacology
·
2
PDF
Effects of an acute dengue, Chikungunya or Zika virus infection during pregnancy: a review
2016
·
Joke Mechels
, Freya Van Avermaete
, et al.
·
European Journal of Obstetrics & Gynecology and Reproductive Biology
·
1
Late Breaking Abstract - Clinical validation of a novel wild type RSV-A challenge agent in healthy adults
2026
·
Nele Verheyen
, Jelle Klein
, et al.
·
European Respiratory Journal
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection
2026
·
Loukas Papargyris
, Jiayun Xu
, et al.
·
Nature Medicine
Show more works
View as search
Works count:
9
Citation count:
156
H-index:
3
I10-index:
3
Year
Topic
Type
